Vicore Pharma Holding AB (publ) (VICO) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.074x

Based on the latest financial reports, Vicore Pharma Holding AB (publ) (VICO) has a cash flow conversion efficiency ratio of -0.074x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-81.48 Million ≈ $-8.77 Million USD) by net assets (Skr1.10 Billion ≈ $117.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Vicore Pharma Holding AB (publ) for the company's overall valuation and market capitalisation.

Vicore Pharma Holding AB (publ) - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Vicore Pharma Holding AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Vicore Pharma Holding AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vicore Pharma Holding AB (publ) ranked by their cash flow conversion efficiency. Explore Vicore Pharma Holding AB (publ) cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Samchully KO:004690	-0.037x
Hengxin Mobile Business SHE:300081	-0.006x
FIC Global Inc TW:3701	0.088x
Build-A-Bear Workshop Inc NYSE:BBW	0.133x
Shenzhen Wenke Landscape Co Ltd SHE:002775	-0.966x
Rana Gruber AS OL:RANA	0.544x
Nalwa Sons Investments Limited NSE:NSIL	0.003x
Firm Capital Mortgage Invest Corp TO:FC	0.024x

Annual Cash Flow Conversion Efficiency for Vicore Pharma Holding AB (publ) (2012–2025)

The table below shows the annual cash flow conversion efficiency of Vicore Pharma Holding AB (publ) from 2012 to 2025. View VICO stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr1.10 Billion ≈ $117.89 Million	Skr-374.44 Million ≈ $-40.30 Million	-0.342x	-134.02%
2024-12-31	Skr1.13 Billion ≈ $121.53 Million	Skr-164.95 Million ≈ $-17.75 Million	-0.146x	+73.35%
2023-12-31	Skr455.39 Million ≈ $49.01 Million	Skr-249.58 Million ≈ $-26.86 Million	-0.548x	+47.17%
2022-12-31	Skr289.08 Million ≈ $31.11 Million	Skr-299.92 Million ≈ $-32.28 Million	-1.037x	-49.97%
2021-12-31	Skr383.32 Million ≈ $41.25 Million	Skr-265.17 Million ≈ $-28.54 Million	-0.692x	-104.48%
2020-12-31	Skr354.51 Million ≈ $38.15 Million	Skr-119.94 Million ≈ $-12.91 Million	-0.338x	-25.06%
2019-12-31	Skr321.60 Million ≈ $34.61 Million	Skr-87.00 Million ≈ $-9.36 Million	-0.271x	-133.73%
2018-12-31	Skr285.44 Million ≈ $30.72 Million	Skr-33.04 Million ≈ $-3.56 Million	-0.116x	-69.69%
2017-12-31	Skr112.97 Million ≈ $12.16 Million	Skr-7.71 Million ≈ $-829.18K	-0.068x	+28.89%
2016-12-31	Skr75.60 Million ≈ $8.14 Million	Skr-7.25 Million ≈ $-780.32K	-0.096x	-113.43%
2015-12-31	Skr81.93 Million ≈ $8.82 Million	Skr-3.68 Million ≈ $-396.24K	-0.045x	+14.58%
2014-12-31	Skr53.70 Million ≈ $5.78 Million	Skr-2.83 Million ≈ $-304.02K	-0.053x	-17.40%
2013-12-31	Skr40.01 Million ≈ $4.31 Million	Skr-1.79 Million ≈ $-192.96K	-0.045x	+29.52%
2012-12-31	Skr26.25K ≈ $2.82K	Skr-1.67K ≈ $-179.61	-0.064x	--

About Vicore Pharma Holding AB (publ)

ST:VICO Sweden Biotechnology

Market Cap

$306.00 Million

Skr2.84 Billion SEK

Market Cap Rank

#14845 Global

#243 in Sweden

Share Price

Skr10.10

Change (1 day)

-2.13%

52-Week Range

Skr9.48 - Skr15.68

All Time High

Skr37.60